466 related articles for article (PubMed ID: 24504806)
1. Absence of interleukin-17 receptor a signaling prevents autoimmune inflammation of the joint and leads to a Th2-like phenotype in collagen-induced arthritis.
Corneth OB; Mus AM; Asmawidjaja PS; Klein Wolterink RG; van Nimwegen M; Brem MD; Hofman Y; Hendriks RW; Lubberts E
Arthritis Rheumatol; 2014 Feb; 66(2):340-9. PubMed ID: 24504806
[TBL] [Abstract][Full Text] [Related]
2. IL-23 is required for protection against systemic infection with Listeria monocytogenes.
Meeks KD; Sieve AN; Kolls JK; Ghilardi N; Berg RE
J Immunol; 2009 Dec; 183(12):8026-34. PubMed ID: 19923464
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells.
Cornelissen F; Mus AM; Asmawidjaja PS; van Hamburg JP; Tocker J; Lubberts E
Arthritis Res Ther; 2009; 11(6):R194. PubMed ID: 20017902
[TBL] [Abstract][Full Text] [Related]
4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
5. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor signaling directly increases functional IL-17RA expression in neuroglial cells.
Liu G; Guo J; Liu J; Wang Z; Liang D
Clin Immunol; 2014 Oct; 154(2):127-40. PubMed ID: 25076485
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
Palmer G; Talabot-Ayer D; Lamacchia C; Toy D; Seemayer CA; Viatte S; Finckh A; Smith DE; Gabay C
Arthritis Rheum; 2009 Mar; 60(3):738-49. PubMed ID: 19248109
[TBL] [Abstract][Full Text] [Related]
8. The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites.
Pineda MA; McGrath MA; Smith PC; Al-Riyami L; Rzepecka J; Gracie JA; Harnett W; Harnett MM
Arthritis Rheum; 2012 Oct; 64(10):3168-78. PubMed ID: 22729944
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cytokine polarization and T cell recruitment to inflamed paws in mouse collagen-induced arthritis by the chemokine receptor CXCR6.
Slauenwhite D; Gebremeskel S; Doucette CD; Hoskin DW; Johnston B
Arthritis Rheumatol; 2014 Nov; 66(11):3001-12. PubMed ID: 25132679
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritis.
Marijnissen RJ; Roeleveld DM; Young D; Nickerson-Nutter C; Abdollahi-Roodsaz S; Garcia de Aquino S; van de Loo FA; van Spriel AB; Boots AM; van den Berg WB; Koenders MI
Arthritis Rheumatol; 2014 Apr; 66(4):886-95. PubMed ID: 24757141
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing IL-23 is superior to blocking IL-17 in suppressing intestinal inflammation in a spontaneous murine colitis model.
Wang R; Hasnain SZ; Tong H; Das I; Che-Hao Chen A; Oancea I; Proctor M; Florin TH; Eri RD; McGuckin MA
Inflamm Bowel Dis; 2015 May; 21(5):973-84. PubMed ID: 25803508
[TBL] [Abstract][Full Text] [Related]
13. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities.
Rickel EA; Siegel LA; Yoon BR; Rottman JB; Kugler DG; Swart DA; Anders PM; Tocker JE; Comeau MR; Budelsky AL
J Immunol; 2008 Sep; 181(6):4299-310. PubMed ID: 18768888
[TBL] [Abstract][Full Text] [Related]
14. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
15. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17RA Promotes Humoral Responses and Glomerular Injury in Experimental Rapidly Progressive Glomerulonephritis.
Ghali JR; O'Sullivan KM; Eggenhuizen PJ; Holdsworth SR; Kitching AR
Nephron; 2017; 135(3):207-223. PubMed ID: 27941331
[TBL] [Abstract][Full Text] [Related]
17. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
18. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
[TBL] [Abstract][Full Text] [Related]
19. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
[TBL] [Abstract][Full Text] [Related]
20. Immune-mediated experimental arthritis in IL-33 deficient mice.
Talabot-Ayer D; Martin P; Seemayer CA; Vigne S; Lamacchia C; Finckh A; Saiji E; Gabay C; Palmer G
Cytokine; 2014 Sep; 69(1):68-74. PubMed ID: 25022964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
